DDa-1 , CAS No.3036944-98-3

CAS: 3036944-98-3 Cat. No.: D1448698 분자식: C60H77Cl2N13O3S 분자량: 1131.31
주문 가능
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
크기
USA
독일 (EU)*
가격
수량
1mg
D1448698-1mg
주문제작 · 8~12주
Enter a quantity for the sizes you want to add.

개요

DDa-1 is a potent BTK degrader (DC 50 : 90 nM). Blue: DCAF1 binder , Black: linker, Pink: BTK ligand.

사양

보관 조건
Store at -20°C
배송
Ice chest + Ice pads
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
작업 유형
DEGRADER
이름과 식별자
분자량
1131.31

고급 데이터

인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
솔루션 계산기
리뷰

고객 리뷰

Application Protocols
  • Item-specific validated applications: Not specified for this item.

  • General protocols for small-molecule screening (general guidance):

    • Stock preparation: dissolve material in anhydrous DMSO to 10–50 mM. Vortex, sonicate, and warm gently (≤40–45°C) if needed. Filter through 0.22 μm PTFE if particulate persists and solution is stable.
    • Aliquoting: dispense single-use aliquots (10–100 μL) into low-bind tubes or 96/384-well plates. Seal to minimize evaporative loss and DMSO uptake of moisture.
    • Serial dilution: perform in DMSO (e.g., 3-fold or 10-fold series), then transfer to assay buffer to achieve desired final concentration range, keeping vehicle constant across wells.
    • Controls: include vehicle-only, positive control (if known for the assay), and orthogonal counterscreens to flag fluorescence/absorbance interference, redox cycling, or aggregation.
    • Data integrity: record lot number, exact stock concentration, preparation date, freeze–thaw count, and storage conditions. Replace stocks after exceeding validated stability window.
  • Analytical verification:

    • Confirm identity/purity by LC–MS before first use and after extended storage. Check UV–Vis for concentration verification when a reliable extinction coefficient is available (not provided for this item).
Biological Roles
  • Item-specific biological function: Not specified for this item; no biological role is assigned in the Product Data.

  • General context for library compounds (general knowledge):

    • Compounds in discovery libraries are not assumed to have endogenous biological roles. Any observed activity arises from experimental screening and is context-dependent (assay, target class, concentration, exposure time).
    • Prior to biological testing, confirm identity and purity, verify absence of interfering impurities (e.g., reactive contaminants, aggregates), and assess solubility/colloidal behavior to avoid assay artifacts.
    • Incorporate counterscreens and orthogonal readouts to discriminate true target engagement from pan-assay interference or redox/photoactive behavior.
  • Note:

    • This product is for research use only and is not intended for diagnostic, therapeutic, or clinical applications.
Buffer Applications
  • Item-specific buffer information: Not specified for this item; refer to CoA/Spec Sheet.

  • Applicability (general guidance):

    • As a small-molecule library member with unknown ionization profile, DDa-1 is not a buffering reagent. However, buffer selection is often critical for biological assays using small molecules.
  • Practical tips for assay buffers (general knowledge):

    • Use a physiologically relevant buffer (e.g., PBS, HEPES, Tris) matched to target pH and ionic strength. Filter-sterilize and degas if needed.
    • When diluting DMSO stocks into buffer, add compound slowly with vigorous mixing to avoid local supersaturation; maintain final DMSO ≤0.1–1.0% v/v as compatible with the assay.
    • Include carrier proteins (e.g., 0.1–0.5% BSA) or mild non-ionic detergents (e.g., 0.01–0.05% Tween-20) only if validated for the assay to mitigate nonspecific binding/aggregation.
    • Record pH before and after addition of concentrated stocks; some compounds can shift pH locally.
  • Not applicable items:

    • No defined pKa or buffering capacity can be provided without structural data.
Green Alternatives
  • Item-specific environmental profile: Not specified for this item; refer to SDS/CoA.

  • Greener choices for common operations involving small molecules (general guidance):

    • Stock solution solvent: if DMSO is not required, consider ethanol or water/ethanol mixtures where solubility and assay compatibility allow, noting their improved EHS profiles.
    • Work-up/extraction: replace dichloromethane with ethyl acetate or 2-MeTHF when feasible; consider aqueous-organic biphasic systems with greener solvents.
    • Chromatography: use ethanol or isopropanol as partial MeOH/ACN replacements in preparative separations when resolution permits.
  • Example comparison (general knowledge):

    • DMSO vs Ethanol for stock prep
      • Safety/EHS: Ethanol is less hazardous and more biodegradable.
      • Performance: DMSO offers broader solubility; ethanol may precipitate highly lipophilic compounds at low temperatures.
    • DCM vs EtOAc for extraction
      • Safety/EHS: EtOAc has lower toxicity and better environmental profile.
      • Performance: EtOAc may give lower partitioning for very nonpolar compounds; adjust pH/ionic strength to compensate.
  • Operational tips:

    • Minimize solvent volumes, employ microscale assays, and use sealed plates/vials to limit VOC emissions.
    • Document solvent choices for reproducibility and to facilitate greener substitutions during scale-up.
Pharmaceutical Uses
  • Item-specific status: Not specified for this item; no pharmacopeial status or excipient role is provided.

  • General note (non-clinical):

    • DDa-1 is supplied for research use only and is not approved for human or veterinary use. No claims are made regarding suitability as an API or excipient.
  • Development workflows (general knowledge):

    • If used in pre-formulation research as a tool compound, typical studies include solubility profiling, stability (pH/oxidative/photolytic), and permeability assessments. Any such work should be strictly non-clinical and for exploratory purposes.
    • Excipient compatibility, residual solvent limits, and impurity profiles would require complete structural disclosure and validated analytical methods; none are available in the current Product Data.
Physical Properties
  • Item-specific facts (from Product Data):

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Thermophysical data (literature/computed):

    • Boiling point, melting point, density, refractive index, logP, pKa, and solubility: Not specified for this item; refer to CoA/Spec Sheet. No literature values can be provided without a disclosed structure.
  • Practical implications (general guidance for small molecules):

    • If solid: expect reconstitution in DMSO or DMF; confirm solubility empirically at small scale (e.g., 1–10 mg in 0.5–1 mL with sonication and gentle heat ≤40–45°C).
    • If oil/liquid: determine miscibility in common solvents (DMSO, MeOH, ACN, EtOH) and record density if gravimetric dosing is planned.
    • Hygroscopicity/photolability are unknown. Handle under low humidity and subdued light until specifications are reviewed.
    • For analytical characterization, LC–MS in ESI+/ESI− with a generic C18 gradient (5–95% ACN/H2O + 0.1% formic acid over 10–15 min) often affords quick confirmation of purity and retention; adjust once UV/ionization properties are known.
Quality and Grades
  • Item-specific information (from Product Data):

    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Guidance on grades (general knowledge):

    • Discovery/screening compounds are commonly supplied at a defined purity threshold (e.g., ≥95% by LC–UV or LC–MS). The exact threshold, analytical method (single-wavelength UV vs. CAD/ELSD), and reporting basis (area% vs. weight%) must be verified on the provided CoA.
    • If a stabilizer, counterion, or solvate/hydrate form is used, it will be disclosed on the CoA; absence of such a note should not be assumed as absence—confirm prior to use in quantitative assays.
    • Recommended incoming QC for critical applications: verify identity by LC–MS, assess purity by HPLC at multiple wavelengths (210/254/280 nm), and check water/volatile content by KF/TGA where relevant. Record lot number for traceability.
  • UV cutoff/trace metals/peroxide content:

    • Not specified for this item; refer to CoA/Spec Sheet. Do not assume suitability for photometric methods without confirming background absorbance.
Reaction and Applications
  • Item-specific application notes (from Product Data):

    • Manufacturer Applications: Not specified for this item; refer to CoA/Spec Sheet.
  • Research use context (general for small-molecule libraries):

    • DDa-1 is categorized under “small molecule and compound libraries,” indicating intended use in screening, SAR exploration, and as a reference material in discovery workflows. Without a disclosed structure, no target- or reaction-specific applications can be assigned.
  • Practical guidance (general):

    • Screening: prepare well-characterized DMSO stocks with documented concentration (UV/gravimetry) and assess stability over study timelines (freeze–thaw and bench-top stability).
    • Orthogonal analytics: employ LC–MS, NMR, and, where applicable, HRMS to monitor identity/purity during campaigns.
    • If used as a tool compound, document lot-to-lot consistency and control for vehicle effects.
  • Synthetic chemistry note:

    • In the absence of structural information, DDa-1 should not be assumed to be a precursor or reagent for a particular transformation. If synthetic modification is intended, obtain full structural data and any IP/usage restrictions from the CoA or supplier documentation before planning reactions.
Reaction Conditions
  • Item-specific conditions: Not applicable—no structure or functional class is provided in the Product Data. No recommended reaction conditions can be stated for this item.

  • General laboratory considerations for handling unknown small molecules (general guidance):

    • Stability screens: test small aliquots under acid/base, oxidative, thermal, and photolytic conditions to map stability domains before any attempted chemical manipulation.
    • Analytical setup: adopt a generic LC–MS gradient (water/ACN + 0.1% formic acid) and room-temperature sampling to avoid unintended reactions.
    • Avoid strong reagents (e.g., conc. mineral acids/bases, strong oxidants/reductants) until compatibility is known.
  • Expected yields/timelines:

    • Not applicable for this item without defined chemistry.
Safety and Handling
  • Item-specific hazard information (from Product Data):

    • Signal Word: Not specified for this item; refer to SDS.
    • H-Statements: Not specified for this item; refer to SDS.
    • GHS Classification/Pictograms: Not specified for this item; refer to SDS.
  • General laboratory precautions (general guidance):

    • Use in a fume hood with appropriate PPE: lab coat, safety glasses, and chemical-resistant gloves (e.g., nitrile). Avoid inhalation of dust/aerosols and skin/eye contact.
    • Unknown toxicity: treat as harmful until proven otherwise. Avoid ingestion and environmental release. Decontaminate surfaces after handling.
    • Storage incompatibilities are unknown; segregate from strong oxidizers, strong acids/bases, and reducing agents by default. Use secondary containment.
    • Spill response: absorb small spills with inert material (vermiculite), collect for disposal as hazardous waste. For solids, avoid raising dust; for liquids, dike to prevent spread.
    • First aid overview: in case of skin/eye contact, rinse with water for at least 15 minutes; if inhaled, move to fresh air; if ingested, do not induce vomiting—seek medical attention. Always follow the SDS when available.
    • Waste disposal: dispose of via licensed chemical waste contractor in accordance with local regulations.
  • Notes:

    • This product is for research use only. Always consult the product-specific SDS for authoritative safety data as soon as it is available.
Solvent Selection
  • Item-specific solubility data: Not specified for this item; refer to CoA/Spec Sheet.

  • Practical starting strategy for unknown small molecules (general guidance):

    • Stock preparation hierarchy: DMSO > DMF > methanol > ethanol > acetonitrile > isopropanol > aqueous buffers with co-solvent.
    • Begin with a 10–50 mM DMSO stock (typical for screening). If solubility is poor, warm gently (≤40–45°C) and sonicate; avoid prolonged heating.
    • For aqueous assays, dilute DMSO stocks into buffered media slowly with vigorous mixing to final DMSO ≤0.1–1.0% v/v, as permitted by the assay.
    • If crystallization occurs upon dilution, add a co-solvent (MeOH or ACN, 5–20% v/v) or include non-ionic surfactants at low levels if compatible with the assay.
  • Chromatography considerations (general):

    • Reverse-phase HPLC/UPLC with C18 columns is broadly compatible. Start with water/ACN or water/MeOH containing 0.1% formic acid (or 5–10 mM ammonium formate for MS compatibility).
  • Comparison of common solvents (general knowledge):

    • DMSO: maximal solvating power; high boiling point; may affect some biological assays at >0.5–1% v/v.
    • MeOH/EtOH: protic, lower toxicity; limited for very lipophilic analytes.
    • ACN: aprotic, low viscosity; strong eluent in RP-HPLC; handle with care due to toxicity.
    • 2-MeTHF/CPME: greener options for synthesis, less typical for stock solutions but useful for extractions.
Storage and Reconstitution
  • Item-specific storage (from Product Data):

    • Storage Conditions: Store at -20°C.
    • Shipped In: Ice chest + ice pads.
  • General handling guidance (applicable to small molecules):

    • Upon receipt: allow the sealed container to equilibrate to room temperature before opening to minimize condensation. Inspect for physical changes.
    • Aliquoting: prepare single-use aliquots to avoid repeated freeze–thaw cycles. For DMSO solutions, store in tightly sealed, moisture-impermeable vials; minimize headspace to limit water uptake.
    • Light/moisture: protection from light and humidity is recommended unless documentation states otherwise.
    • Reconstitution: solvent choice depends on solubility (not provided). Start with anhydrous DMSO; if aqueous use is required, dilute slowly into buffer with vigorous mixing. Document final vehicle composition.
    • Stability: no item-specific stability data are provided. Establish bench-top and frozen stability empirically (e.g., LC–MS at t0, 24 h, 1 week). Replace solutions that show precipitation, discoloration, or degradation.
  • Specifications not provided for this item; refer to CoA/Spec Sheet:

    • Exact solubility and concentration limits
    • Extinction coefficient for UV-based quantitation
    • Photostability and hygroscopicity
    • Recommended shelf life at -20°C
  • Research Use Note: For research use only.

Structure and Identity
  • Item-specific facts (from Product Data):

    • SKU: D1448698
    • Product Name: DDa-1
    • CAS: 3036944-98-3
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural description:

    • The structural features (ring systems, functional groups, stereochemistry) cannot be summarized because no structure (SMILES/InChI) is provided in the Product Data. Refer to the product CoA/Spec Sheet for definitive identity information.
  • General notes for small-molecule library members (general knowledge):

    • Library compounds like DDa-1 are typically discrete organic molecules intended for screening and discovery workflows. Without an exact structure, treat this as a research chemical of unknown functional class until documentation is reviewed.
    • Best practice: Verify identity via CoA (including structure drawing, spectral data) and, if needed, perform independent confirmation (LC–MS, HRMS, 1H/13C NMR) before critical studies.
Synthetic Utility
  • Item-specific reactivity/functional group content: Not specified for this item; structure is not disclosed in the Product Data.

  • Applicability (general guidance):

    • Without structural information, DDa-1 should not be assumed to function as a reagent, catalyst, or building block. Treat as a finalized small molecule intended for screening rather than for synthetic elaboration.
  • If derivatization is contemplated (general knowledge):

    • Obtain full structural data and IP status. Plan orthogonal handles for modification only after confirming functional groups and stability.
    • Analytical controls: monitor reactions by LC–MS and NMR; confirm absence of decomposition if sensitive motifs (e.g., aldehydes, anilines, diazo, nitroso) are later identified.
  • Bottom line:

    • Use as a test article/reference compound unless and until the structure and reactivity profile are defined via official documentation.
Target Specificity
  • Item-specific data: Not specified for this item; no target, epitope, or specificity information is provided in the Product Data.

  • General note:

    • For small-molecule library members, any target specificity must be established experimentally. Use target engagement assays and orthogonal biophysical methods (e.g., SPR, DSF, CETSA, enzymology) where appropriate.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.